Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

21.12.2020 back forward

First Marketing Authorisation of a COVID-19 Vaccine

COVID-19 Vaccines (Source: M-Photo / Shutterstock)

On 21 December 2020, the European Commission issues a conditional marketing authorisation for the BioNTech/Pfizer mRNA vaccine against COVID-19. This follows a recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on the same day.

On the next day, the Paul-Ehrlich-Institut releases the first vaccine batches for the German and European market. At an early stage, experts from the Paul-Ehrlich-Institut had developed and validated test methods for testing the innovative mRNA vaccines.

Essential work in Times of Pandemic